BrightPath Biotherapeutics Co (TSE:4594) Net Interest Margin (Bank Only) %


TSE:4594 BrightPath Biotherapeutics Co Ltd TSE:4594
46 GF Score
Price 円50.00
GF Value 円4.64
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is BrightPath Biotherapeutics Co Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

TSE:4594
46GF Score
BrightPath Biotherapeutics Co Ltd TSE:4594
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BrightPath Biotherapeutics Co (TSE:4594) Overvalued in 2026?

Based on GuruFocus' analysis, BrightPath Biotherapeutics Co stock appears to be overvalued. The current stock price of 円50.00 is trading 977.6% above its estimated GF Value™ of 円4.64. GuruFocus considers BrightPath Biotherapeutics Co to be Significantly Overvalued.

Key valuation signals for TSE:4594:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: 円4.64 vs. price of 円50.00 (977.6% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the TSE:4594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BrightPath Biotherapeutics Co Business Description

Address 2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
46GF Score

Get the complete analysis for TSE:4594

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円50.00
Price
円4.64
GF Value